Artículos con órdenes de acceso público - Giridhar MudduluruMás información
No disponibles en ningún lugar: 3
Urokinase receptor, MMP‐1 and MMP‐9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies
D Buergy, T Weber, GD Maurer, G Mudduluru, F Medved, JH Leupold, ...
International journal of cancer 125 (4), 894-901, 2009
Órdenes: German Research Foundation
MACC1, a novel player in solid cancer carcinogenesis
G Mudduluru, K Ilm, M Dahlmann, U Stein
Mechanisms of Molecular Carcinogenesis–Volume 1, 11-38, 2017
Órdenes: Federal Ministry of Education and Research, Germany
Axl and Its Mediated Signaling Axis in Cancer
G Mudduluru
Mechanisms of Molecular Carcinogenesis–Volume 1, 39-60, 2017
Órdenes: Federal Ministry of Education and Research, Germany
Disponibles en algún lugar: 7
S100A4 in cancer metastasis: Wnt signaling-driven interventions for metastasis restriction
M Dahlmann, D Kobelt, W Walther, G Mudduluru, U Stein
Cancers 8 (6), 59, 2016
Órdenes: German Research Foundation
Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer
LD Nelson, C Bender, H Mannsperger, D Buergy, P Kambakamba, ...
Molecular cancer 11, 1-17, 2012
Órdenes: US National Institutes of Health
Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression
G Mudduluru, K Ilm, S Fuchs, U Stein
Oncotarget 8, 21081-21094, 2017
Órdenes: Federal Ministry of Education and Research, Germany
Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance
MA Moreno-Mateos, V Barragán, B Torres, C Rodríguez-Mateo, ...
Rna 19 (12), 1711-1725, 2013
Órdenes: Gobierno de España
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy
VB Venkadakrishnan, AD DePriest, S Kumari, D Senapati, S Ben-Salem, ...
Oncogene 38 (23), 4496-4511, 2019
Órdenes: US Department of Defense, US National Institutes of Health
Targeted therapy for EBV-associated B-cell neoplasms
S Ganguly, S Kuravi, S Alleboina, G Mudduluru, RA Jensen, JP McGuirk, ...
Molecular Cancer Research 17 (4), 839-844, 2019
Órdenes: US National Institutes of Health
CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
S Kuravi, E Parrott, G Mudduluru, J Cheng, S Ganguly, Y Saunthararajah, ...
Blood cancer journal 9 (2), 14, 2019
Órdenes: US National Institutes of Health
La información de publicación y financiación se determina de forma automática mediante un programa informático